PharmaCielo Ltd. (TSXV:PCLO)

Market Cap	8.46M
Revenue (ttm)	2.71M
Net Income (ttm)	-7.82M
Shares Out	187.98M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,615
Average Volume	3,731
Open	0.0500
Previous Close	0.0450
Day's Range	0.0450 - 0.0500
52-Week Range	0.0250 - 0.2300
Beta	1.65
RSI	42.31
Earnings Date	Dec 1, 2025

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marc Lustig
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCLO

Financial Performance

In 2024, PharmaCielo's revenue was 3.17 million, a decrease of -8.81% compared to the previous year's 3.48 million. Losses were -9.10 million, -0.50% less than in 2024.